Infectious Diseases
August 15, 2022
ROCHESTER, Minn. — Mayo Clinic researchers say the monoclonal antibody bebtelovimab, already authorized by the Food and Drug Administration for emergency use on the omicron[...]
January 19, 2016
January 17, 2016
January 14, 2016
January 13, 2016
December 29, 2015
December 21, 2015
December 18, 2015
December 14, 2015
December 10, 2015
December 9, 2015
Explore more topics
Sign up
Mayo Clinic Connect
An online patient support community